CORD-19:2e2bc679c8393230bac2af64115bab7ed1ba62c0 / 234830-235011 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T270","span":{"begin":0,"end":181},"obj":"Sentence"}],"text":"There is preliminary evidence that the bradykinin B 2 receptor antagonist icatibant that is approved for treatment of HAE type I and II may also be eff ective in ACEI-induced edema."}

{"project":"CORD-19-Sentences","denotations":[{"id":"T97512","span":{"begin":0,"end":181},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"There is preliminary evidence that the bradykinin B 2 receptor antagonist icatibant that is approved for treatment of HAE type I and II may also be eff ective in ACEI-induced edema."}

{"project":"Epistemic_Statements","denotations":[{"id":"T412","span":{"begin":0,"end":181},"obj":"Epistemic_statement"}],"text":"There is preliminary evidence that the bradykinin B 2 receptor antagonist icatibant that is approved for treatment of HAE type I and II may also be eff ective in ACEI-induced edema."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T426","span":{"begin":175,"end":180},"obj":"Phenotype"}],"attributes":[{"id":"A426","pred":"hp_id","subj":"T426","obj":"http://purl.obolibrary.org/obo/HP_0000969"}],"text":"There is preliminary evidence that the bradykinin B 2 receptor antagonist icatibant that is approved for treatment of HAE type I and II may also be eff ective in ACEI-induced edema."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T702","span":{"begin":118,"end":121},"obj":"Disease"},{"id":"T703","span":{"begin":127,"end":128},"obj":"Disease"},{"id":"T688","span":{"begin":118,"end":121},"obj":"Disease"}],"attributes":[{"id":"A702","pred":"mondo_id","subj":"T702","obj":"http://purl.obolibrary.org/obo/MONDO_0019623"},{"id":"A703","pred":"mondo_id","subj":"T703","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A96386","pred":"mondo_id","subj":"T688","obj":"http://purl.obolibrary.org/obo/MONDO_0019623"}],"text":"There is preliminary evidence that the bradykinin B 2 receptor antagonist icatibant that is approved for treatment of HAE type I and II may also be eff ective in ACEI-induced edema."}